Skip to main content

Decibel Therapeutics, Inc.

DBTXDelisted Sep 25, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001656536

Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Decibel Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of DBTX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders5446−8
Shares20.0M19.6M−353.3K (−1.8%)
Value$226.3M$168.1M−$58.2M (−25.7%)

New holders (11)

Institutions that held Decibel Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to DBTX in Q2 2021
InstitutionSharesValue% of portfolio
Credit Suisse AG253,851$2.18M0.00%
Bronte Capital Management Pty Ltd.159,462$1.37M0.21%
Bridgeway Capital Management, LLC72,000$619.0K0.01%
Tibra Equities Europe Ltd43,400$373.0K0.12%
Alberta Investment Management Corp30,000$258.0K0.00%
Atlas Capital Advisors LLC17,798$153.1K0.03%
Renaissance Technologies LLC15,900$137.0K0.00%
Jacobs Levy Equity Management, Inc13,594$117.0K0.00%
O'Shaughnessy Asset Management, LLC12,821$110.0K0.00%
Advisory Services Network, LLC1,000$9.00K0.00%
Optiver Holding B.V.867$7.00K0.00%

Sold out (19)

Institutions that held Decibel Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.